semaglutide with sodium Mechanism of absorption of oral semaglutide. SNAC indicates Why Scientists Are Urging Caution

January 2026 milestone: The FDA approved an oral formulation of Wegovy (semaglutide) for chronic weight management in December 2025 the first GLP-1 pill ever approved for obesity treatment

A: We expect retatrutide to primarily serve patients who do not achieve sufficient weight loss with current GLP-1based therapies, particularly those with high cardiometabolic risk

Current trial phase and status can be verified via ClinicalTrials.gov or the EU Clinical Trials Register

As Wegovy should not be used during pregnancy, women of childbearing age should use effective contraception whilst using Wegovy

Form(s): prefilled single-dose pen, prefilled multi-dose KwikPen (semaglutide): a weekly injection Ozempic approved to improve blood sugar control in adults with type 2 diabetes, reduce cardiovascular risk in adults with type 2 diabetes and heart disease, and slow kidney decline in adults with type 2 diabetes and chronic kidney disease